Event: VacTech 2011
Dates: March 29 - 30, 2011
Venue: TBD, Shanghai, China
Contact: Bob Lee
Tel: +86 21 5172 0126
China has little difference in the quantity of vaccine but quality and manufacturing techniques with other developed countries. Chinese government gives high prominence to the R&D and manufacturing of vaccine companies and spares 200 million RMB from the project of Vaccine and Antibody Engineering in '863 Plan' to support the development of vaccine industry, together with 60 million to the manufacturing of the important traditional vaccine and quality improvement. Under such circumstances, VacTech 2011 will disclose its curtain on March 29 - 30 to give a deep insight on technological innovation from R&D to manufacturing, pushing vaccine industry to a higher level!
Key themes and issues to be discussed include:
- Design and development for novel vaccines;
- New Adjuvant & Its Mechanism;
- Immune Mechanism and Immune Suppression of Combined Vaccine;
- Difficulties and Mechanism of Therapeutic Vaccine;
- Cell Culture in Vaccine R&D and Manufacturing;
- Vaccine Purification and Downstream Processing Technology;
- Vaccine Research, Development and Manufacturing Tools;
- Clinical design and proceedings;
- Vaccine Storage and Transportation Technology;
- Progress of genetic vaccine; and
- Nanotech on vaccine research and development.